Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 799 results for "eli lilly"

Analyst Update: Infoblox Inc, Marvell Technology Group Ltd., and Eli Lilly and Co
Schaeffers Research

Why Eli Lilly (LLY) Stock Is Gaining Today

NEW YORK (TheStreet) -- Shares of drug manufacturer Eli Lilly (LLY - Get Report) are rising 5.03% to $86.17 in late-afternoon trading on Tuesday, after an upgrade to "overweight" from "equal weight" at Barclays today. The firm raised its price ..., 11 hours ago

162 images for eli lilly

Ticker Report, 2 hours ago
American Banking News, 1 hour ago
BioSpace, 11 hours ago
Bidness Etc, 10 hours ago
Inside INdiana Business, 6 days ago
Pharmaceutical Journal, 13 hours ago
Inside INdiana Business, 1 week ago
Yahoo! Finance, 1 week ago
PR Newswire, 1 week ago
WISH-TV, 6 days ago

Why TerraForm Power, Shoe Carnival, and Eli Lilly Jumped Today

Lilly was among the stronger performers in the stock market Tuesday. Image: Eli Lilly. The stock market started December strongly as investors ignored somewhat downbeat economic data in favor of their belief that 2015 will finish with a ...
 Motley Fool5 hours ago

3 Big Pharma Upgrades (And One Downgrade) At Barclays

B ig pharmas Merck (NYSE: MRK ), Eli Lilly (NYSE: LLY ) and Johnson & Johnson (NYSE: JNJ ) were trading up Tuesday after getting upgrades from Barclays, while AbbVie (NYSE: ABBV ) seesawed on a downgrade. Analyst Geoff Meacham assumed coverage of ...
 Investor's Business Daily10 hours ago Benzinga's Top Upgrades  Benzinga.com17 hours ago
Bidness Etc

Has Anavex Just Become Attractive for Biogen Inc, Eli Lilly and Co?

Anavex Life Sciences Corp. ( NASDAQ:AVXL ) may have just emerged as a significant player in the Alzheimer's drug market. The clinical-stage biotech company specializes in the development of treatments for currently incurable diseases. It has ...
 Bidness Etc10 hours ago

Eli Lilly Breakout Confirms Our Thesis

Get all the benefits of membership for two weeks and see how your portfolio can profit from: Instant access to Jim Cramer's blog, where he posts multiple times each day while the market is open 30+ investing pros, money managers and financial ...
 TheStreet.com13 hours ago
Nikkei Asian Review

Lilly: Education an Antidote for Understanding Drug Development

There's a knowledge gap in the health care industry, say leaders at Indianapolis-based pharmaceutical giant Eli Lilly and Company. The company believes, despite years of specialized education, many in the health care industry—from students to ...
 Inside INdiana Business13 hours ago ELI LILLY : U.S. Patents Awarded to Inventors in Kansas (Nov. 20)  4 Traders1 week ago ELI LILLY : Deciphera Pharmaceuticals, Eli Lilly Assigned Patent  4 Traders1 week ago Partnerships better than acquisitions for Eli Lilly  Nikkei Asian Review2 weeks ago

Merck, J&J and Lilly shares climb after upgrades at Barclays

Shares of Merck & Co. (MRK) climbed 1.4%, Johnson & Johnson (JNJ) rose 0.4% and Eli Lilly & Co. (LLY) surged 2.7% in morning trade Tuesday, after the drug makers were all upgraded to overweight from equal weight at Barclays, which cited optimism ...
 TD Ameritrade16 hours ago

Abasaglar ▼

Company: Eli Lilly and Co (Ireland) Ltd. Legal category: Prescription. GMS reimbursable. Sport prohibited. Active ingredient: Insulin glargine 100units/ml. Description: Solution for injection. Presentation: 5 x 3ml cartridges, €45.80; ...
 Irish Medical Times19 hours ago LILLY ELI & CO (0000059478) (Filed by)  SEC Filings2 weeks ago 4/A - LILLY ELI & CO (0000059478) (Issuer)  SEC2 weeks ago

Eli Lilly and Company wins US FDA's approval for Portrazza for first-line treatment of metastatic squamous non-small cell lung cancer

Healthcare company Eli Lilly and Company (NYSE:LLY) disclosed on Tuesday that it has been given US Food and Drug Administration (FDA) approval for Portrazza (necitumumab injection for intravenous use, 800 mg/50 ml) for the first-line treatment of ...
 Bloomberg6 days ago Eli Lilly's Portrazza Gets FDA Nod, Carries Boxed Warning  Zacks.com6 days ago FDA clears Lilly's Portrazza for lung cancer  Seeking Alpha1 week ago

Eli Lilly Is Overvalued- Too Costly To Buy

Summary Eli Lilly's net-debt increased by whopping 1789.87% over the past five years. Strong U.S. dollar is an issue for Eli Lilly. Pharmaceuticals industry continues to lose exclusivities, including Eli Lilly. On October 22, Eli Lilly ...
 Seeking Alpha1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Related Queries - eli lilly
Get updated on latest news & your favorite topics right in your inbox!
More     Less